SEC Filing Document

Company: Synergy CHC Corp.
Ticker: SNYR
CIK: 1562733
Filing Type: 10-K
Document Type: EX-19.1
Date Filed: 2025-03-31
Accession Number: 0001213900-25-026254
Exchange: Nasdaq
SIC Code: 2833
SIC Description: Medicinal Chemicals & Botanical Products
URL: https://www.sec.gov/Archives/edgar/data/1562733/000121390025026254/ea023575801ex19-1_synergy.htm

Chunk 1 of 4
Word Count: 1409
Character Count: 9001

Document Content:

and investor relations personnel may communicate with securities market professionals, stockholders and members of the media. Employees, officers and directors should refer any such inquiries to the appropriate Company personnel as indicated above. Insiders are also prohibited from trading in the securities of competitors, customers, vendors or joint venturers of the Company while in possession of material non-public information concerning those third parties. No director, officer or employee or any of their immediate family members may purchase or sell, or offer to purchase or sell, any Company security, whether or not issued by the Company, while in possession of material nonpublic information about the Company. No director, officer or employee or any of their immediate family members who knows of any material nonpublic information about the Company may communicate that information to (“tip”) any other person, including family members and friends, or otherwise disclose such information without the Company’s authorization.

No director, officer or employee or any of their immediate family members
may purchase or sell any security of any other publicly-traded company while in possession of material nonpublic information that was
obtained in the course of his or her involvement with the Company. No director, officer or employee or any of their immediate family members
who knows of any such material nonpublic information may communicate that information to, or tip, any other person, including family members
and friends, or otherwise disclose such information without the Company’s authorization.

For compliance purposes, you should never trade, tip or recommend securities
(or otherwise cause the purchase or sale of securities) while in possession of information that you have reason to believe is material
and nonpublic unless you first consult with, and obtain the advance approval of, the Secretary.

Covered Persons must “pre-clear” all trading in securities
of the Company in accordance with the procedures set forth below.

C.	Possible Sanctions

Violation of any of the securities laws described in this Policy Statement
may result in the institution of a prosecution or an SEC enforcement proceeding against the individual and the Company, or both. Some
of the possible penalties for individuals who trade on inside information include:

●	Liability
for Insider Trading . Insiders may be subject to a civil penalty of up to three times the profit gained or loss avoided; a criminal
fine of up to $5 million (no matter how small the profit); and imprisonment for up to 20 years for trading in securities when in possession
of material non-public information. In addition, if the Company or any “controlling person” (i.e., a person in a supervisory
capacity) fails to take appropriate steps to prevent an employee from engaging in insider trading, the Company or controlling person
faces potential civil penalties of the greater of $1,000,000, up to 3 times the profits realized or losses avoided, and potential criminal
penalties of up to $25 million.

●	Liability for Tipping . Insiders may also be liable for improper transactions
by a tippee to whom they have disclosed material non-public information, or to whom they have made recommendations or expressed opinions
on the basis of such information about trading securities. The SEC has imposed large penalties even when the disclosing person did not
profit from the trading.

●	Possible Disciplinary Actions . Employees who violate this policy will
be subject to serious disciplinary action, which may include ineligibility for future participation in our equity incentive plans or termination
of employment.

D.	Quiet Periods and Pre-Trade Approvals

In order to provide a degree of certainty as to when insider trading
is permissible with respect to the timing of quarterly and annual releases of financial information, the Company has established recurring
“quiet periods” relative to such releases. Directors, all officers and employees with access to financial results, subject
to their having adopted a valid 10b5-1 plan, as discussed below, are not permitted to buy or sell Company stock during the periods commencing
on the 16th calendar day of the third month of each fiscal quarter and ending at the close of business on the second working day after
quarterly or annual earnings are released to the public. Trading in Company stock at other times may be permissible, but all transactions
in Company stock by directors, officers and other identified employees must be approved in advance by the Secretary and must be reported
to the Secretary after consummating the transaction.

The Company may impose additional quiet periods during which
trading will not be allowed when there are developments that give rise to the need for public disclosure. Affected stockholders will be
advised by memorandum from the Secretary when these additional quiet periods are in effect.

E.	10b5-1 Trading Plans

The SEC has enacted rules (Rule 10b5-1 under the Exchange Act) that
provide an affirmative defense against violations of the insider trading laws if you enter into a contract, provide instructions, or adopt
a written plan for a transaction in securities when you are not in possession of material, nonpublic information, even if it turns out
that you had such information when the transaction is actually completed. The contract, instructions, or plan must:

●	specify the amount, price and date of the transaction,

●	specify an objective method for determining the amount, price and date of
the transaction, or

●	place the discretion for determining amount, price, and date of the transaction
in another person who is not, at the time of the transaction, in possession of material, nonpublic information.

You may not exercise discretion or influence over the amount, price,
and date of the transaction after entering into the arrangement. In this Policy, we refer to these arrangements as “Trading Plans.”
The rules regarding Trading Plans are extremely complex and must be complied with completely to be effective. You should consult with
your own legal advisor before proceeding with entering into any Trading Plan.

Any restrictions under this Policy that apply to you when purchasing
or selling the Company’s securities also apply to you when establishing a Trading Plan. Therefore, you may not establish a Trading
Plan when you are in possession of material, nonpublic information about the Company and, to the extent trading windows and special blackout
periods apply to you, those restrictions must be complied with in connection with establishing a Trading Plan. All employees, officers
and directors are required to receive pre-clearance from the Secretary before entering into, modifying or terminating any Trading Plan.
Once a Trading Plan has been pre-cleared by the Secretary, transactions executed pursuant to that Trading Plan do not require approval.
However, as noted in Section III, if you are a director or an executive officer, you must immediately report all transactions
executed under a Trading Plan to the Secretary so that a Form 4 may be filed on your behalf.

In establishing any Trading Plan, you should carefully consider the
timing of your transactions under the Trading Plan. Even though transactions executed in accordance with a bona-fide Trading Plan
are exempt from the insider trading rules, the trades may nonetheless occur at times shortly before the Company announces material news,
and the media may not understand the nuances of trading pursuant to a Trading Plan. Finally, modification or termination of any Trading
Plan carries with it considerable risk, including the risk that previously executed transactions that occurred under the Trading Plan
may be viewed as improper insider trades. For this reason, you should not modify or terminate any Trading Plan without first consulting
with your own legal advisor and obtaining prior approval from the Secretary.

II. RESTRICTION ON SHORT-SWING TRADING AND SHORT SALES

A.	Purchases and Sales Within Six Months

Section 16(b) of the Exchange Act imposes liability on executive officers,
members of the board of directors and certain large stockholders of the Company if they have a purchase and sale, or sale and purchase,
of Company stock within a period of less than six months (referred to as a “short-swing” trade). This section provides that
the Company, or any stockholder who brings a lawsuit on behalf of the Company, may recover the amount of any “profit” realized
by such individual on a short-swing trade. It should be noted, however, that while Section 16(b) and the reporting requirements
discussed under Section III rest on the premise that such persons are likely to possess inside information, the actual possession of the
information is not a precondition to liability being imposed. In other words, because Section 16(b) is so strict, good faith in engaging
in short-swing trading is irrelevant.